follow @RheumNews
RSS Feeds
Find Us on Facebook

Lupus/Connective Tissue Diseases

Methotrexate May Benefit Juvenile Scleroderma

10/07/10

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

Children with localized scleroderma responded better to methotrexate than to prednisone in a small, placebo-controlled trial, Dr. Francesco Zulian reports.

View Video Now.

> more Connective Tissue Diseases articles


Sign-up to receive the Rheumatology e-newsletter
I would like to receive Rheumatology News E-Newsletter each week.


Specialty Focus
Sponsored by


calendar
Jun 6 - 9
Berlin,
EULAR (European League Against Rheumatism): 2012 Congress
Aug 23 - 25
San Francisco, CA
University of California, San Francisco (UCSF): Rheumatology Board Review and Clinical Update
Sep 2 - 5
Copenhagen,
Scandinavian Congress of Rheumatology (SCR)
Sep 28 - 29
Newport Beach, CA
5th Annual Perspectives in Rheumatic Diseases presented by Rheumatology News, Internal Medicine News & Family Practice News
Nov 9 - 14
Washington, DC
American College of Rheumatology (ACR): Annual Scientific Meeting
Nov 14 - 17
Prague,
Connective Tissue Oncology Society (CTOS): Annual Meeting
Jan 26 - Feb 1
,
American College of Rheumatology (ACR): Winter Rheumatology Symposium
Feb 6 - 9
Maui, HI
Rheumatology Winter Clinical Symposium 2013
Feb 13 - 16
Ottawa,
Canadian Rheumatology Association (CRA): Scientific Conference and Annual General Meeting
Sep 21 - 25
Natal,
11th World Congress on Inflammation
More Calendar »